InvestorsHub Logo
Followers 12
Posts 376
Boards Moderated 0
Alias Born 04/24/2012

Re: None

Friday, 07/22/2016 12:33:01 AM

Friday, July 22, 2016 12:33:01 AM

Post# of 41254
Elute's Elutebone

"Elute aims to be the leader in developing and commercializing a new class of polymer-controlled drug delivery devices designed to prevent and treat orthopedic and other surgical bone infections...Our patented and patent pending polymer / ceramic-based platform eliminates the toxic burst release associated with currently available antibiotic loaded bone void fillers."

Amedica's founding CEO working with the current CEO. homologous. Si3N4

http://elutinc.com/clinical/

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News